SCHEMBL5111928

SCHEMBL5111928

CCOC(=O)C1(NC(=O)OC(C)(C)C)CC1(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
TSHR P16473 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
HCRTR2 O43614 1/20 0.34
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
CA1 P00915 2/20 0.33
CA7 P43166 2/20 0.33
CA12 O43570 1/20 0.33
CA14 Q9ULX7 1/20 0.33
APLNR P35414 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
CTSL P07711 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17226329 0.79 KMT2A (0.37) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL11941451 0.79 MEN1 (0.33) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL4646027 0.78 MEN1 (0.37) KMT2AMEN1HCRTR2MAPK1CA1
SCHEMBL21222679 0.78 KMT2A (0.36) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL583634 0.78 KMT2A (0.38) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL8200484 0.77 KMT2A (0.39) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL5427004 0.77 KMT2A (0.39) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL1967793 0.76 MEN1 (0.35) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL21222559 0.76 KMT2A (0.39) KMT2AALDH1A1MEN1TSHRCYP1A2
SCHEMBL1351011 0.75 LATS1 (0.37) KMT2AALDH1A1MEN1TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348344-B2 Polysubstituted 1,1-pyridyloxycyclopropanamine compounds LES LABORATOIRES SERVIER (FR) 2008-03-25 US disclosed
US-20070027191-A1 Polysubstituted 1,1-pyridyloxycyclopropanamine compounds LES LABORATOIRES SERVIER (FR) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027191-A1 Polysubstituted 1,1-pyridyloxycyclopropanamine compounds CHRM1, CHRNA1, CHRNA9 KMT2A 2244/4885ALDH1A1 680/4885MEN1 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.